亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Fine Mapping Of PEDF Anti-Angiogenic Activity

技術優勢
Alternative for VEGF therapy
詳細技術說明
PEDF, a novel therapeutic agent for cancer treatment.#therapeutics #biomarker #cancer #ophthalmology
*Abstract

Northwestern researchers have identified an alternate target for cancer therapy. While VEGF has shown some promise in the treatment of some cancers, it has not been successful in many other tumor types, suggesting that other factors or components play a critical role in suppressing tumor angiogenesis. The researchers have identified PEDF (pigment epithelium derived factor) to be an additional factor that can be used to modulate angiogenesis and treat angiogenesis-mediated disease. They have identified peptides derived from PEDF with potent suppressive function in eye disease and cancer.

*Inventors
Yelena MirochnikOlga Volpert*
國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備